Empyrean Neuroscience is a revolutionary brand that is at the forefront of genetic engineering in the field of neuroscience. They are dedicated to transforming the way severe neuropsychiatric and neurologic diseases are treated. Empyrean has developed a groundbreaking platform that enables them to genetically engineer small molecule therapeutics from both fungi and plants, allowing them to discover new compounds.

This platform addresses a significant gap in the treatment of neuropsychiatric and neurological disorders. Their team is focused on developing innovative therapies to meet the ongoing unmet needs of patients suffering from conditions like depression, post-traumatic stress disorder, substance abuse disorders, and pain. By harnessing the power of genetic engineering, Empyrean can unlock the full potential of neuroactive compounds produced by plants and fungi, offering hope to those affected by devastating diseases.

With locations in New York, NY and Cambridge, UK, Empyrean is committed to advancing the frontiers of neuroscience and improving the lives of patients worldwide. Discover more about their cutting-edge platform, learn about their dedicated team, explore career opportunities, and stay up to date with the latest news and events on their website. Empyrean Neuroscience is paving the way for a brighter future in neuroscience research and therapy